Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis. [electronic resource]
Producer: 20150707Description: 875-83 p. digitalISSN:- 1365-2133
- Adalimumab
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Biological Factors -- administration & dosage
- Drug Administration Schedule
- Drug Substitution
- Female
- Humans
- Infliximab
- Male
- Middle Aged
- Prospective Studies
- Psoriasis -- drug therapy
- Quality of Life
- Severity of Illness Index
- Treatment Outcome
- Ustekinumab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.